Clover Health Investments Corp.
| NASDAQ: CLOV |
| Healthcare / Healthcare Plans / USA |
| 2.23 | -0.1000 | -4.29% | Vol 52.32M | 1Y Perf -83.10% |
| Jun 24th, 2022 16:00 DELAYED |
| BID | 2.20 | ASK | 2.23 | ||
| Open | 2.37 | Previous Close | 2.33 | ||
| Pre-Market | - | After-Market | 2.26 | ||
| - - | 0.03 1.35% |
| Target Price | 3.50 | Analyst Rating | Hold 2.80 | |
| Potential % | 56.95 | Finscreener Ranking | — - | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ★+ 43.51 | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | ★ 33.75 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
| Price Range Ratio 52W % | 2.13 | Earnings Rating | — | |
| Market Cap | 982.76M | Earnings Date | 10th Aug 2022 | |
| Alpha | -0.08 | Standard Deviation | 0.30 | |
| Beta | 2.16 |
Today's Price Range 2.212.39 | 52W Range 1.9515.10 |
Summary:
Sell
| Technical Indicators: | Neutral |
| Moving Averages: | Strong Sell |
| Performance | |||
|---|---|---|---|
| 1 Week | 0.45% | ||
| 1 Month | -12.89% | ||
| 3 Months | -36.65% | ||
| 6 Months | -46.90% | ||
| 1 Year | -83.10% | ||
| 3 Years | - | ||
| 5 Years | - | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | - | |||
ROE last 12 Months | -119.16 | |||
ROA (5Y Avg) | - | |||
ROA last 12 Months | -35.30 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -98.81 | |||
Return on invested Capital Q | -12.90 | |||
Return on invested Capital Y | -85.66 | |||
Assets Turnover | 1.40 | |||
Receivables Turnover | 2.20 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -1.50 | ||||
| 2.15 | ||||
| 0.46 | ||||
| - | ||||
| -4.20 | ||||
| -0.56 | ||||
| 2.15 | ||||
| 1.03 | ||||
| 595.38M | ||||
| Forward PE | - | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 1.10 | ||||
| 1.20 | ||||
| 0.05 | ||||
| 0.22 | ||||
| -247.00 | ||||
| Leverage Ratio | 3.40 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -2.70 | ||||
| -28.50 | ||||
| -28.40 | ||||
| - | ||||
| -27.94 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 2.15B | ||||
| 4.87 | ||||
| - | ||||
| - |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q01 2022 | -0.24 | -0.19 | 20.83 |
| Q04 2021 | -0.26 | -0.44 | -69.23 |
| Q03 2021 | -0.31 | -0.08 | 74.19 |
| Q02 2021 | -0.17 | -0.45 | -164.71 |
| Q01 2021 | -0.12 | -0.13 | -8.33 |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Next Report Date | 10th Aug 2022 |
| Estimated EPS Next Report | -0.23 |
| Estimates Count | 2 |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 52.32M |
| Shares Outstanding | 440.70K |
| Shares Float | 82.80M |
| Trades Count | 38.30K |
| Dollar Volume | 117.62M |
| Avg. Volume | 9.43M |
| Avg. Weekly Volume | 11.04M |
| Avg. Monthly Volume | 8.88M |
| Avg. Quarterly Volume | 8.38M |
Clover Health Investments Corp. (NASDAQ: CLOV) stock closed at 2.23 per share at the end of the most recent trading day (a -4.29% change compared to the prior day closing price) with a volume of 52.32M shares and market capitalization of 982.76M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 458 people. Clover Health Investments Corp. CEO is Vivek Garipalli.
The one-year performance of Clover Health Investments Corp. stock is -83.1%, while year-to-date (YTD) performance is -40.05%. CLOV stock has a five-year performance of %. Its 52-week range is between 1.95 and 15.1, which gives CLOV stock a 52-week price range ratio of 2.13%
Clover Health Investments Corp. currently has a PE ratio of -1.50, a price-to-book (PB) ratio of 2.15, a price-to-sale (PS) ratio of 0.46, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -35.30%, a ROC of -98.81% and a ROE of -119.16%. The company’s profit margin is -27.94%, its EBITDA margin is -28.40%, and its revenue ttm is $2.15 Billion , which makes it $4.87 revenue per share.
Of the last four earnings reports from Clover Health Investments Corp., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.23 for the next earnings report. Clover Health Investments Corp.’s next earnings report date is 10th Aug 2022.
The consensus rating of Wall Street analysts for Clover Health Investments Corp. is Hold (2.8), with a target price of $3.5, which is +56.95% compared to the current price. The earnings rating for Clover Health Investments Corp. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Clover Health Investments Corp. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Clover Health Investments Corp. has a Sell technical analysis rating based on Technical Indicators (ADX : 14.47, ATR14 : 0.18, CCI20 : -40.15, Chaikin Money Flow : -0.28, MACD : -0.12, Money Flow Index : 34.58, ROC : -12.20, RSI : 42.29, STOCH (14,3) : 34.27, STOCH RSI : 0.62, UO : 42.83, Williams %R : -65.73), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Clover Health Investments Corp. in the last 12-months were:
Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients.
CEO: Vivek Garipalli
Telephone: +1 201 432-2133
Address: 725 Cool Springs Boulevard, Franklin 37067, TN, US
Number of employees: 458
